Literature DB >> 11430802

Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy.

D L Sherman1, C Fabrizi, C S Gillespie, P J Brophy.   

Abstract

Dystroglycan-dystrophin complexes are believed to have structural and signaling functions by linking extracellular matrix proteins to the cytoskeleton and cortical signaling molecules. Here we characterize a dystroglycan-dystrophin-related protein 2 (DRP2) complex at the surface of myelin-forming Schwann cells. The complex is clustered by the interaction of DRP2 with L-periaxin, a homodimeric PDZ domain-containing protein. In the absence of L-periaxin, DRP2 is mislocalized and depleted, although other dystrophin family proteins are unaffected. Disruption of the DRP2-dystroglycan complex is followed by hypermyelination and destabilization of the Schwann cell-axon unit in Prx(-/-) mice. Hence, the DRP2-dystroglycan complex likely has a distinct function in the terminal stages of PNS myelinogenesis, possibly in the regulation of myelin thickness.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430802     DOI: 10.1016/s0896-6273(01)00327-0

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  54 in total

Review 1.  Signaling axis in schwann cell proliferation and differentiation.

Authors:  Toru Ogata; Shin-ichi Yamamoto; Kozo Nakamura; Sakae Tanaka
Journal:  Mol Neurobiol       Date:  2006-02       Impact factor: 5.590

Review 2.  Glia unglued: how signals from the extracellular matrix regulate the development of myelinating glia.

Authors:  Holly Colognato; Iva D Tzvetanova
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

3.  Sustained MAPK/ERK Activation in Adult Schwann Cells Impairs Nerve Repair.

Authors:  Ilaria Cervellini; Jorge Galino; Ning Zhu; Shannen Allen; Carmen Birchmeier; David L Bennett
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

4.  Late-onset Charcot-Marie-Tooth disease 4F caused by periaxin gene mutation.

Authors:  Shoko Tokunaga; Akihiro Hashiguchi; Akiko Yoshimura; Kengo Maeda; Takashi Suzuki; Hiroyo Haruki; Tomonori Nakamura; Yuji Okamoto; Hiroshi Takashima
Journal:  Neurogenetics       Date:  2012-08-01       Impact factor: 2.660

5.  Remodeling of motor nerve terminals in demyelinating axons of periaxin-null mice.

Authors:  Felipe A Court; Peter J Brophy; Richard R Ribchester
Journal:  Glia       Date:  2008-03       Impact factor: 7.452

6.  Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin Maintenance and Axon Integrity.

Authors:  Sungsu Kim; Jason C Maynard; Yo Sasaki; Amy Strickland; Diane L Sherman; Peter J Brophy; Alma L Burlingame; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

7.  Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination.

Authors:  Anura Rambukkana; Stefan Kunz; Jenny Min; Kevin P Campbell; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

8.  The ABCA1 cholesterol transporter associates with one of two distinct dystrophin-based scaffolds in Schwann cells.

Authors:  Douglas E Albrecht; Diane L Sherman; Peter J Brophy; Stanley C Froehner
Journal:  Glia       Date:  2008-04-15       Impact factor: 7.452

Review 9.  Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.

Authors:  Toshihiro Masaki; Kiichiro Matsumura
Journal:  J Biomed Biotechnol       Date:  2010-06-15

Review 10.  Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.

Authors:  Caroline Perronnet; Cyrille Vaillend
Journal:  J Biomed Biotechnol       Date:  2010-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.